Company: VERA
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029969
Chunk: 137

Company: Vera Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 137
---
99

VERA THERAPEUTICS, INC. 

Index to Financial Statements

Years ended December 31, 2024 and 2023

    PageNumber

    Report of Independent Registered Public Accounting Firm     (PCAOB ID: 185)
    101

     Financial Statements:

    Balance Sheets
    103

    Statements of Operations and Comprehensive Loss
    104

    Statements of Stockholders’ Equity
    105

    Statements of Cash Flows
    106

    Notes to Financial Statements
    107

100

Report of Independent Registered Public Accounting Firm

To the Stockholders and the Board of DirectorsVera Therapeutics, Inc.:

Opinions on the Financial Statements and Internal Control Over Financial Reporting We have audited the accompanying balance sheets of Vera Therapeutics, Inc. (the Company) as of December 31, 2024 and 2023, the related statements of operations and comprehensive loss, stockholders’ equity, and cash flows for the years then ended, and the related notes (collectively, the financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

Basis for Opinions

The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are